AusBiotech Calls For More Australian Support For Collaborations
This article was originally published in PharmAsia News
Australia's biotechnology industry needs substantial help from the government, particularly for early-stage innovation, if it is to realize its potential, AusBiotech says. The 3,000-member association said there is a need for a government investment in research and development for pharmaceuticals in general, but that biotechnology needs to be included in that program. AusBiotech CEO Anna Lavelle said in an opinion piece the government needs to nurture the current trend of global companies collaborating beyond their borders, including in Australia, but the industry has seen little evidence of government help for the biotech industry in Australia. (Click here for more
You may also be interested in...
Abbott reported third-quarter 2020 global sales of $8.9bn, driven by its strong position in COVID-19 tests. See what Abbott’s CEO Robert Ford said about it here.
From enforced detention to hefty fines, China's newly passed Biosecurity Law will fundamentally change how the life science sector handles human genetic resources over years to come, legal experts say.
Ahead of the vaccine advisory committee, requests to FDA range from public health groups opposing emergency use authorizations to industry seeking labeling guidance on EUA products.